-
公开(公告)号:US20230232797A1
公开(公告)日:2023-07-27
申请号:US18175010
申请日:2023-02-27
发明人: Qing Fang , Chia-Jen Siao , Dan Chalothorn , KehDih Lai , Leah Sabin , Rachel Sattler , Brian Zambrowicz , Lori Morton
IPC分类号: A01K67/027 , A61K49/00 , C07K14/76 , C12N15/85
CPC分类号: A01K67/0278 , A61K49/0008 , C07K14/76 , C12N15/8509 , A01K2207/15 , A01K2227/105 , A01K2267/03 , C12N2015/8527
摘要: Non-human animal genomes, non-human animal cells, and non-human animals comprising a humanized albumin (ALB) locus and methods of making and using such non-human animal genomes, non-human animal cells, and non-human animals are provided. Non-human animal cells or non-human animals comprising a humanized albumin locus express a human albumin protein or a chimeric albumin protein, fragments of which are from human albumin. Methods are provided for using such non-human animals comprising a humanized albumin locus to assess in vivo efficacy of human-albumin-targeting reagents such as nuclease agents designed to target human albumin.
-
公开(公告)号:US20210274759A1
公开(公告)日:2021-09-09
申请号:US17190650
申请日:2021-03-03
发明人: Giusy Della Gatta , Qing Fang , Alan Shuldiner
IPC分类号: A01K67/027 , C12N15/11 , C12N9/22 , C12N9/10
摘要: This disclosure relates to genetically modified animals. More specifically, this disclosure relates to rodent animals in which an endogenous B4galt1 gene has been modified, e.g., to introduce a mutation that encodes an Asn to Ser substitution in the encoded B4galt1 protein at a position corresponding to position 352 in a human B4GALT1 protein, or to introduce a loss of function mutation (e.g., in a select tissue such as the liver). This disclosure also relates to use of such rodent animals in elucidating the role of B4galt1 in lipid metabolism.
-
公开(公告)号:US11622547B2
公开(公告)日:2023-04-11
申请号:US16894302
申请日:2020-06-05
发明人: Qing Fang , Chia-Jen Siao , Dan Chalothorn , KehDih Lai , Leah Sabin , Rachel Sattler , Brian Zambrowicz , Lori Morton
IPC分类号: A01K67/027 , A61K49/00 , C07K14/76 , C12N15/85
摘要: Non-human animal genomes, non-human animal cells, and non-human animals comprising a humanized albumin (ALB) locus and methods of making and using such non-human animal genomes, non-human animal cells, and non-human animals are provided. Non-human animal cells or non-human animals comprising a humanized albumin locus express a human albumin protein or a chimeric albumin protein, fragments of which are from human albumin. Methods are provided for using such non-human animals comprising a humanized albumin locus to assess in vivo efficacy of human-albumin-targeting reagents such as nuclease agents designed to target human albumin.
-
-